Quotient Limited (NASDAQ:QTNT) announced its quarterly earnings results on Monday. The company reported ($0.58) EPS for the quarter, topping analysts’ consensus estimates of ($0.59) by $0.01, reports. Quotient Limited had a negative net margin of 381.66% and a negative return on equity of 13,050.41%.

Shares of Quotient Limited (NASDAQ QTNT) traded down 0.38% during mid-day trading on Monday, reaching $5.19. 285,910 shares of the company traded hands. The firm has a 50-day moving average price of $4.75 and a 200 day moving average price of $5.85. The firm’s market capitalization is $74.61 million. Quotient Limited has a 52 week low of $3.22 and a 52 week high of $7.74.

In related news, insider D J. Paul E. Cowan sold 100,000 shares of the firm’s stock in a transaction that occurred on Monday, September 18th. The stock was sold at an average price of $4.41, for a total value of $441,000.00. Following the sale, the insider now owns 26,666 shares of the company’s stock, valued at approximately $117,597.06. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, insider D J. Paul E. Cowan sold 45,540 shares of the firm’s stock in a transaction that occurred on Monday, August 21st. The stock was sold at an average price of $3.52, for a total value of $160,300.80. Following the completion of the sale, the insider now directly owns 26,666 shares in the company, valued at approximately $93,864.32. The disclosure for this sale can be found here. In the last three months, insiders sold 375,197 shares of company stock worth $1,639,728. Company insiders own 29.00% of the company’s stock.

Hedge funds and other institutional investors have recently made changes to their positions in the stock. The Manufacturers Life Insurance Company bought a new stake in Quotient Limited during the 2nd quarter valued at $177,000. California State Teachers Retirement System bought a new stake in Quotient Limited during the 2nd quarter valued at $349,000. Vanguard Group Inc. bought a new stake in Quotient Limited during the 2nd quarter valued at $523,000. Finally, State Street Corp bought a new stake in Quotient Limited during the 2nd quarter valued at $1,728,000. 57.68% of the stock is currently owned by institutional investors and hedge funds.

Several analysts recently issued reports on the stock. Zacks Investment Research lowered shares of Quotient Limited from a “hold” rating to a “strong sell” rating in a research report on Wednesday, July 26th. ValuEngine lowered shares of Quotient Limited from a “sell” rating to a “strong sell” rating in a research report on Friday, September 1st. Finally, BTIG Research restated a “buy” rating and set a $12.00 target price on shares of Quotient Limited in a research report on Thursday, August 31st.

COPYRIGHT VIOLATION NOTICE: “Quotient Limited (QTNT) Posts Earnings Results, Beats Expectations By $0.01 EPS” was reported by American Banking News and is the property of of American Banking News. If you are reading this story on another site, it was illegally copied and reposted in violation of US and international copyright & trademark laws. The correct version of this story can be accessed at https://www.americanbankingnews.com/2017/10/30/quotient-limited-qtnt-posts-earnings-results-beats-expectations-by-0-01-eps.html.

About Quotient Limited

Quotient Limited is a diagnostics company. The Company focuses on blood grouping and donor disease screening, which is referred to as transfusion diagnostics. It is engaged in developing, manufacturing and commercializing conventional reagent products used for blood grouping within the global transfusion diagnostics market.

Earnings History for Quotient Limited (NASDAQ:QTNT)

Receive News & Ratings for Quotient Limited Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quotient Limited and related companies with MarketBeat.com's FREE daily email newsletter.